Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 6, Number 5, May 2008

Free Content Polymorphisms in coagulation factors and the risk of recurrent cardiovascular events in men after a first myocardial infarction
pp. 720-725(6)
Authors: VAN DER KRABBEN, M. D.; ROSENDAAL, F. R.; VAN DER BOM, J. G.; DOGGEN, C. J. M.

Favourites:
ADD

Free Content Human urotensin II induces tissue factor and cellular adhesion molecules expression in human coronary endothelial cells: an emerging role for urotensin II in cardiovascular disease
pp. 726-736(11)
Authors: CIRILLO, P.; DE ROSA, S.; PACILEO, M.; GARGIULO, A.; ANGRI, V.; FIORENTINO, I.; PREVETE, N.; PETRILLO, G.; DE PALMA, R.; LEONARDI, A.; DE PAULIS, A.; CHIARIELLO, M.

Favourites:
ADD

Free Content Alanine aminotransferase is associated with atherothrombotic risk factors in a British South Asian population
pp. 737-741(5)
Authors: KAIN, K.; CARTER, A. M.; GRANT, P. J.; SCOTT, E. M.

Favourites:
ADD

Free Content Myocardial infarction and cerebrovascular accident following non‐cardiac surgery: differences in postoperative temporal distribution and risk factors
pp. 742-748(7)
Authors: KIKURA, M.; OIKAWA, F.; YAMAMOTO, K.; IWAMOTO, T.; TANAKA, K. A.; SATO, S.; LANDESBERG, G.

Favourites:
ADD

Free Content Predicting the future: it’s not a SNP
pp. 749-750(2)
Author: KEELING, D.

Favourites:
ADD

Free Content Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis
pp. 751-754(4)
Authors: VAN HYLCKAMA VLIEG, A.; BAGLIN, C. A.; BARE, L. A.; ROSENDAAL, F. R.; BAGLIN, T. P.

Favourites:
ADD

Free Content Health‐related quality of life in a cohort of adult patients with mild hemophilia A
pp. 755-761(7)
Authors: WALSH, M.; MACGREGOR, D.; STUCKLESS, S.; BARRETT, B.; KAWAJA, M.; SCULLY, M.‐F.

Favourites:
ADD

Free Content Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD)
pp. 762-771(10)
Authors: BUDDE, U.; SCHNEPPENHEIM, R.; EIKENBOOM, J.; GOODEVE, A.; WILL, K.; DREWKE, E.; CASTAMAN, G.; RODEGHIERO, F.; FEDERICI, A. B.; BATLLE, J.; PÉREZ, A.; MEYER, D.; MAZURIER, C.; GOUDEMAND, J.; INGERSLEV, J.; HABART, D.; VORLOVA, Z.; HOLMBERG, L.; LETHAGEN, S.; PASI, J.; HILL, F.; PEAKE, I.

Favourites:
ADD

Free Content Prospective multicenter evaluation of the pulmonary embolism rule‐out criteria
pp. 772-780(9)
Authors: KLINE, J. A.; COURTNEY, D. M.; KABRHEL, C.; MOORE, C. L.; SMITHLINE, H. A; PLEWA, M. C.; RICHMAN, P. B.; O'NEIL, B. J.; NORDENHOLZ, K.

Favourites:
ADD

Free Content Venous thromboembolic events and organ‐specific occult cancers: a review and meta‐analysis
pp. 781-788(8)
Authors: IODICE, S.; GANDINI, S.; LÖHR, M.; LOWENFELS, A. B.; MAISONNEUVE, P.

Favourites:
ADD

Free Content A randomized, repeat‐dose, pharmacodynamic and safety study of an antidote‐controlled factor IXa inhibitor
pp. 789-796(8)
Authors: CHAN, M. Y.; RUSCONI, C. P.; ALEXANDER, J. H.; TONKENS, R. M.; HARRINGTON, R. A.; BECKER, R. C.

Favourites:
ADD

Free Content Vitamin K‐induced modification of coagulation phenotype in VKORC1 homozygous deficiency
pp. 797-803(7)
Authors: MARCHETTI, G.; CARUSO, P.; LUNGHI, B.; PINOTTI, M.; LAPECORELLA, M.; NAPOLITANO, M.; CANELLA, A.; MARIANI, G.; BERNARDI, F.

Favourites:
ADD

Free Content Recombinant human factor VIIa and a factor VIIa‐analogue reduces heparin and low molecular weight heparin (LMWH)‐induced bleeding in rats
pp. 804-811(8)
Authors: LAURITZEN, B.; HEDNER, U.; JOHANSEN, P. B.; TRANHOLM, M.; EZBAN, M.

Favourites:
ADD

Free Content Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function
pp. 812-819(8)
Authors: PALUMBO, J. S.; BARNEY, K. A.; BLEVINS, E. A.; SHAW, M. A.; MISHRA, A.; FLICK, M. J.; KOMBRINCK, K. W.; TALMAGE, K. E.; SOURI, M.; ICHINOSE, A.; DEGEN, J. L.

Favourites:
ADD

Free Content Apixaban, an oral, direct and highly selective factor Xa inhibitor: in vitro, antithrombotic and antihemostatic studies
pp. 820-829(10)
Authors: WONG, P. C.; CRAIN, E. J.; XIN, B.; WEXLER, R. R.; LAM, P. Y. S.; PINTO, D. J.; LUETTGEN, J. M.; KNABB, R. M.

Favourites:
ADD
Favourites:
ADD

Free Content Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo
pp. 837-845(9)
Authors: NIEMAN, M. T.; BURKE, F.; WARNOCK, M.; ZHOU, Y.; SWEIGART, J.; CHEN, A.; RICKETTS, D.; LUCCHESI, B. R.; CHEN, Z.; DI CERA, E.; HILFINGER, J.; KIM, J. S.; MOSBERG, H. I.; SCHMAIER, A. H.

Favourites:
ADD
Favourites:
ADD

Free Content Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity
pp. 848-855(8)
Authors: WALKER, J. B.; BINETTE, T. M.; MACKOVA, M.; LAMBKIN, G. R.; MITCHELL, L.; BAJZAR, L.

Favourites:
ADD
Favourites:
ADD

Free Content Circulating endothelial cells: from bench to clinical practice
pp. 865-868(4)
Authors: SHANTSILA, E.; BLANN, A. D.; LIP, G. Y. H.

Favourites:
ADD

Free Content CD146‐based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells
pp. 869-876(8)
Authors: WIDEMANN, A.; SABATIER, F.; ARNAUD, L.; BONELLO, L.; AL‐MASSARANI, G.; PAGANELLI, F.; PONCELET, P.; DIGNAT‐GEORGE, F.

Favourites:
ADD

Free Content SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells
pp. 877-884(8)
Authors: TARDOS, J. G.; EISENREICH, A.; DEIKUS, G.; BECHHOFER, D. H.; CHANDRADAS, S.; ZAFAR, U.; RAUCH, U.; BOGDANOV, V. Y.

Favourites:
ADD

Free Content A case of non‐resolving hemophilia B Leyden in a 42‐year‐old male (F9 promoter + 13 A>G)
pp. 885-886(2)
Authors: JAMES, P. D.; STAKIW, J.; LEGGO, J.; WALKER, I.; LILLICRAP, D.

Favourites:
ADD

Free Content Prevalence of type 2b ‘Malmö/New York’ von Willebrand disease in Italy: the role of von Willebrand factor gene conversion
pp. 887-890(4)
Authors: BARONCIANI, L.; FEDERICI, A. B.; CASTAMAN, G.; PUNZO, M.; MANNUCCI, P. M.

Favourites:
ADD

Free Content Long elimination half‐life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials
pp. 890-892(3)
Authors: HARENBERG, J.; VUKOJEVIC, Y.; MIKUS, G.; JOERG, I.; WEISS, C.

Favourites:
ADD

Free Content Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I
pp. 893-895(3)
Authors: TOLAR, J.; ORCHARD, P. J.; KEY, N. S.; BLAZAR, B. R.

Favourites:
ADD

Free Content Join ISTH
pp. 896-896(1)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more